U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07345091) titled 'Feasibility Performance Study of ABL90 FLEX PLUS HEM' on Sept. 11, 2025.
Brief Summary: This feasibility performance study evaluates the ABL90 FLEX PLUS HEM device for its analytical performance in a clinical setting. The study aims to evaluate the performance of the hemolysis detection feature.
Study Start Date: Aug. 04, 2025
Study Type: OBSERVATIONAL
Condition:
Hemolysis
Intervention:
DIAGNOSTIC_TEST: The purpose of this study is to investigate the performance of the hemolysis detection function on the ABL90 FLEX PLUS HEM using arterial or venous whole blood
The hemolysis detection function is a newly developed sample quali...